Dipesh Uprety

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

Egbert F. Smit, Enriqueta Felip, Dipesh Uprety et al. · The Lancet Oncology · 2024 · 123 citations · Full text

Oncology, Primary Results, Her2-overexpressing Cohorts +9

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Hossein Borghaei, Filippo de Marinis, Daphne W. Dumoulin et al. · Annals of Oncology · 2023 · 78 citations · Full text

Nivolumab Versus Docetaxel, Medicine, Pharmacology +7

ChatGPT—A promising generative AI tool and its implications for cancer care

Dipesh Uprety, Dongxiao Zhu, Howard West · Cancer · 2023 · 63 citations · Full text

Youtube as a source of information on cervical cancer

Dipesh Uprety, Janak Adhikari, Priyadarshani Sharma et al. · North American Journal of Medical Sciences · 2016 · 53 citations · Full text

Utilization of Surgery and Its Impact on Survival in Patients With Early Stage Small-cell Lung Cancer in the United States

Dipesh Uprety, Lubina Arjyal, Yazhini Vallatharasu et al. · Clinical Lung Cancer · 2019 · 41 citations

Surgical Oncology, Medicine, Cancer Management +8